Health
Evidence of robust and persistent antibodies against SARS-CoV-2 – News-Medical.Net
A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions…
A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions surrounding the coronavirus disease 19 (COVID-19) pandemic: do antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) last after a primary infection? And, if the antibodies remain active, for how long can they be relied upon as protection against the infection? Over 47.3 million people worldwide have been…
-
Business20 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General6 hours agoDefence minister won’t say if security agencies or Trump administration pushed for Darwin Port backflip
-
Business19 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News16 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites